The Fort Worth Press - High doses of Adderall linked with heightened risk of psychosis and mania

USD -
AED 3.672505
AFN 64.502368
ALL 81.998222
AMD 357.803769
ANG 1.790403
AOA 918.000351
ARS 1559.243988
AUD 1.491024
AWG 1.8025
AZN 1.697591
BAM 1.782854
BBD 2.012735
BDT 124.411466
BGN 1.77347
BHD 0.377107
BIF 3003.463993
BMD 1
BND 1.288879
BOB 11.707704
BRL 5.899
BSD 0.999385
BTN 93.383593
BWP 14.117915
BYN 2.997958
BYR 19600
BZD 2.009818
CAD 1.431095
CDF 2285.00014
CHF 0.842915
CLF 0.025574
CLP 1006.490009
CNY 6.667797
CNH 6.668405
COP 3354.71
CRC 444.296568
CUC 1
CUP 23.984575
CVE 100.51779
CZK 22.22175
DJF 177.949763
DKK 6.802565
DOP 60.418499
DZD 137.053072
EGP 53.820098
ERN 15
ETB 164.020438
EUR 0.91005
FJD 2.28525
FKP 0.76038
GBP 0.760375
GEL 2.590602
GGP 0.76038
GHS 11.732317
GIP 0.76038
GMD 73.499493
GNF 8859.697901
GTQ 7.637401
GYD 209.002981
HKD 7.844715
HNL 26.862474
HRK 6.831965
HTG 131.020966
HUF 335.920292
IDR 18253
ILS 3.282095
IMP 0.76038
INR 93.28535
IQD 1514.984389
IRR 1933164.496166
ISK 124.679944
JEP 0.76038
JMD 158.502846
JOD 0.709056
JPY 159.949498
KES 130.060512
KGS 87.449537
KHR 4071.103008
KMF 448.999585
KPW 900.00035
KRW 1328.189719
KWD 0.31162
KYD 0.832836
KZT 444.440393
LAK 22515.053033
LBP 89590.84067
LKR 332.58429
LRD 167.887437
LSL 17.179374
LTL 2.95274
LVL 0.60489
LYD 6.463111
MAD 9.953508
MDL 18.347645
MGA 4544.315048
MKD 55.964687
MMK 2099.801407
MNT 3600.814049
MOP 8.076574
MRU 40.612196
MUR 46.840266
MVR 15.416238
MWK 1732.793079
MXN 18.845105
MYR 4.113204
MZN 63.915562
NAD 17.179061
NGN 1351.659682
NIO 36.77352
NOK 9.693335
NPR 149.412703
NZD 1.80985
OMR 0.384501
PAB 0.999385
PEN 3.411744
PGK 4.495877
PHP 63.690193
PKR 276.292258
PLN 4.01981
PYG 6255.270079
QAR 3.643308
RON 4.864696
RSD 107.053982
RUB 81.823857
RWF 1478.922348
SAR 3.751382
SBD 8.137041
SCR 13.883305
SDG 601.50065
SEK 10.14478
SGD 1.289585
SHP 0.757117
SLE 22.795018
SLL 20969.503664
SOS 571.095199
SRD 37.384497
STD 20697.981008
STN 22.333535
SVC 8.744046
SYP 13002.000337
SZL 17.176326
THB 33.896501
TJS 9.188906
TMT 3.5
TND 3.026701
TOP 2.40776
TRY 50.46722
TTD 6.7815
TWD 32.936502
TZS 2655.017981
UAH 45.116247
UGX 4186.987794
UYU 40.602566
UZS 12002.151381
VES 916.62795
VND 25755
VUV 120.949122
WST 2.823281
XAF 596.953744
XAG 0.022206
XAU 0.000268806004
XCD 2.70255
XCG 1.801044
XDR 0.707052
XOF 596.953744
XPF 108.71765
YER 236.550276
ZAR 17.251035
ZMK 9001.198647
ZMW 20.525699
ZWL 321.999592
SSP 5879.599296
MXV 2.113026
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

High doses of Adderall linked with heightened risk of psychosis and mania
High doses of Adderall linked with heightened risk of psychosis and mania / Photo: © AFP

High doses of Adderall linked with heightened risk of psychosis and mania

Adderall is an effective treatment for attention deficit hyperactivity disorder (ADHD), but a sharp rise in US prescriptions over the past two decades has sparked concerns among researchers about rare but serious side effects.

Text size:

In a striking new study published Thursday, a team led by psychiatrist Lauren Moran of Mass General Brigham in Boston found that individuals taking high doses of the stimulant face more than a fivefold increased risk of developing psychosis or mania.

Key factors include the lack of upper dosing guidelines and the notable increase in young adults using the medicine since the Covid-19 pandemic, driven in large part by the rise of telemedicine providers.

Moran told AFP her interest grew from her time at a hospital inpatient unit treating college students in the greater Boston area.

"We were just seeing a lot of people coming in without much of a psychiatric history, developing the first episode of psychosis or mania in the context of using prescription stimulants," she said.

When the Food and Drug Administration became aware of such cases in the 2000s, it added a warning to the drug's label -- but relatively little research had been done to quantify the rates of side effects or how they related to the dosage level.

For their investigation, Moran and colleagues reviewed the electronic health records of people aged 16 to 35 admitted at Mass General Brigham hospitals between 2005 and 2019. That is the typical onset ages for psychosis, or losing touch with reality.

The researchers identified 1,374 individuals experiencing their first episode of psychosis or mania -- a disruptive state characterized by high energy, erratic behavior -- and compared them to 2,748 control patients who were hospitalized for other psychiatric conditions.

By analyzing Adderall use during the previous month and adjusting for other variables like substance use, they were able to specifically determine the impact of stimulants.

They found those who had taken Adderall were 2.68 times more likely to have been hospitalized with psychosis or mania compared to those who were not -- and this increased to 5.28 times more likely at higher doses of 40 milligrams and above.

A separate analysis found no increased risk with Ritalin, another stimulant prescribed for ADHD. Moran suggested this could be due to key differences in how the two drugs work.

- Telemedicine companies -

Both medications raise dopamine levels, a chemical messenger involved in the brain's reward system, motivation, and learning. However, while Adderall, an amphetamine, increases dopamine release, Ritalin works by blocking its reabsorption.

For Moran, a critical takeaway was the need for clear upper dose limits on labels. The current label recommends treating patients with 20 milligrams, but in practice, doctors vary widely in their prescriptions.

This variability partly stems from severe impairment in ADHD symptoms that require higher doses, but Moran has occasionally observed "carelessness in dose prescribing," while at other times, patients may "shop" for a doctor willing to prescribe what they want.

"People, including clinicians, might think they can eliminate all ADHD symptoms, but that's not a realistic expectation," she added.

Telemedicine companies, in particular, have come under scrutiny for allegedly overprescribing Adderall, contributing to shortages for those who genuinely need the medication.

The Drug Enforcement Administration, which had proposed revoking telehealth prescriptions for Adderall, extended them through the end of 2024 in response to significant public feedback.

C.Dean--TFWP